Logo image of TRNS

TRANSCAT INC (TRNS) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:TRNS - US8935291075 - Common Stock

63.67 USD
-2.2 (-3.34%)
Last: 1/13/2026, 8:00:01 PM
63.67 USD
0 (0%)
After Hours: 1/13/2026, 8:00:01 PM
Fundamental Rating

5

Taking everything into account, TRNS scores 5 out of 10 in our fundamental rating. TRNS was compared to 50 industry peers in the Trading Companies & Distributors industry. Both the profitability and the financial health of TRNS get a neutral evaluation. Nothing too spectacular is happening here. TRNS is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year TRNS was profitable.
In the past year TRNS had a positive cash flow from operations.
Each year in the past 5 years TRNS has been profitable.
In the past 5 years TRNS always reported a positive cash flow from operatings.
TRNS Yearly Net Income VS EBIT VS OCF VS FCFTRNS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

1.2 Ratios

With a Return On Assets value of 2.34%, TRNS perfoms like the industry average, outperforming 42.00% of the companies in the same industry.
The Return On Equity of TRNS (3.84%) is worse than 62.00% of its industry peers.
TRNS has a Return On Invested Capital of 3.29%. This is in the lower half of the industry: TRNS underperforms 64.00% of its industry peers.
TRNS had an Average Return On Invested Capital over the past 3 years of 6.00%. This is below the industry average of 9.63%.
Industry RankSector Rank
ROA 2.34%
ROE 3.84%
ROIC 3.29%
ROA(3y)4.66%
ROA(5y)5.25%
ROE(3y)7.28%
ROE(5y)9.09%
ROIC(3y)6%
ROIC(5y)6.74%
TRNS Yearly ROA, ROE, ROICTRNS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

TRNS has a Profit Margin (3.75%) which is comparable to the rest of the industry.
In the last couple of years the Profit Margin of TRNS has grown nicely.
With a Operating Margin value of 6.39%, TRNS perfoms like the industry average, outperforming 52.00% of the companies in the same industry.
TRNS's Operating Margin has improved in the last couple of years.
TRNS has a Gross Margin (32.45%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of TRNS has grown nicely.
Industry RankSector Rank
OM 6.39%
PM (TTM) 3.75%
GM 32.45%
OM growth 3Y-2.14%
OM growth 5Y1.69%
PM growth 3Y-2.08%
PM growth 5Y2.27%
GM growth 3Y4.06%
GM growth 5Y5.54%
TRNS Yearly Profit, Operating, Gross MarginsTRNS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), TRNS is destroying value.
Compared to 1 year ago, TRNS has more shares outstanding
Compared to 5 years ago, TRNS has more shares outstanding
The debt/assets ratio for TRNS is higher compared to a year ago.
TRNS Yearly Shares OutstandingTRNS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M
TRNS Yearly Total Debt VS Total AssetsTRNS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.2 Solvency

TRNS has an Altman-Z score of 3.11. This indicates that TRNS is financially healthy and has little risk of bankruptcy at the moment.
TRNS's Altman-Z score of 3.11 is in line compared to the rest of the industry. TRNS outperforms 48.00% of its industry peers.
TRNS has a debt to FCF ratio of 4.45. This is a neutral value as TRNS would need 4.45 years to pay back of all of its debts.
The Debt to FCF ratio of TRNS (4.45) is better than 62.00% of its industry peers.
TRNS has a Debt/Equity ratio of 0.38. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of TRNS (0.38) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 4.45
Altman-Z 3.11
ROIC/WACC0.34
WACC9.72%
TRNS Yearly LT Debt VS Equity VS FCFTRNS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

2.3 Liquidity

A Current Ratio of 2.43 indicates that TRNS has no problem at all paying its short term obligations.
With a decent Current ratio value of 2.43, TRNS is doing good in the industry, outperforming 64.00% of the companies in the same industry.
TRNS has a Quick Ratio of 2.06. This indicates that TRNS is financially healthy and has no problem in meeting its short term obligations.
TRNS has a Quick ratio of 2.06. This is in the better half of the industry: TRNS outperforms 76.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.43
Quick Ratio 2.06
TRNS Yearly Current Assets VS Current LiabilitesTRNS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

6

3. Growth

3.1 Past

The earnings per share for TRNS have decreased strongly by -15.66% in the last year.
TRNS shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 6.36% yearly.
Looking at the last year, TRNS shows a quite strong growth in Revenue. The Revenue has grown by 11.81% in the last year.
TRNS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.97% yearly.
EPS 1Y (TTM)-15.66%
EPS 3Y-2.79%
EPS 5Y6.36%
EPS Q2Q%25.71%
Revenue 1Y (TTM)11.81%
Revenue growth 3Y10.75%
Revenue growth 5Y9.97%
Sales Q2Q%21.3%

3.2 Future

The Earnings Per Share is expected to grow by 19.42% on average over the next years. This is quite good.
TRNS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.30% yearly.
EPS Next Y47.1%
EPS Next 2Y31.71%
EPS Next 3Y16.78%
EPS Next 5Y19.42%
Revenue Next Year18.13%
Revenue Next 2Y12.77%
Revenue Next 3Y9.23%
Revenue Next 5Y9.3%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
TRNS Yearly Revenue VS EstimatesTRNS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M 400M
TRNS Yearly EPS VS EstimatesTRNS Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3

3

4. Valuation

4.1 Price/Earnings Ratio

TRNS is valuated quite expensively with a Price/Earnings ratio of 38.13.
62.00% of the companies in the same industry are cheaper than TRNS, based on the Price/Earnings ratio.
TRNS is valuated rather expensively when we compare the Price/Earnings ratio to 27.30, which is the current average of the S&P500 Index.
TRNS is valuated rather expensively with a Price/Forward Earnings ratio of 24.97.
Compared to the rest of the industry, the Price/Forward Earnings ratio of TRNS is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 24.04. TRNS is around the same levels.
Industry RankSector Rank
PE 38.13
Fwd PE 24.97
TRNS Price Earnings VS Forward Price EarningsTRNS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

TRNS's Enterprise Value to EBITDA is on the same level as the industry average.
Based on the Price/Free Cash Flow ratio, TRNS is valued a bit cheaper than the industry average as 74.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 23.63
EV/EBITDA 17.39
TRNS Per share dataTRNS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

TRNS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as TRNS's earnings are expected to grow with 16.78% in the coming years.
PEG (NY)0.81
PEG (5Y)5.99
EPS Next 2Y31.71%
EPS Next 3Y16.78%

0

5. Dividend

5.1 Amount

No dividends for TRNS!.
Industry RankSector Rank
Dividend Yield 0%

TRANSCAT INC

NASDAQ:TRNS (1/13/2026, 8:00:01 PM)

After market: 63.67 0 (0%)

63.67

-2.2 (-3.34%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)11-03 2025-11-03/amc
Earnings (Next)02-02 2026-02-02
Inst Owners98.89%
Inst Owner Change0.16%
Ins Owners0.99%
Ins Owner Change1.01%
Market Cap594.04M
Revenue(TTM)302.58M
Net Income(TTM)11.35M
Analysts80
Price Target105.74 (66.08%)
Short Float %4.47%
Short Ratio3.17
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)15.93%
Min EPS beat(2)-14.58%
Max EPS beat(2)46.44%
EPS beat(4)2
Avg EPS beat(4)2.63%
Min EPS beat(4)-24%
Max EPS beat(4)46.44%
EPS beat(8)5
Avg EPS beat(8)8.39%
EPS beat(12)7
Avg EPS beat(12)3.58%
EPS beat(16)8
Avg EPS beat(16)2.32%
Revenue beat(2)2
Avg Revenue beat(2)2.55%
Min Revenue beat(2)1.44%
Max Revenue beat(2)3.66%
Revenue beat(4)2
Avg Revenue beat(4)-0.71%
Min Revenue beat(4)-6.92%
Max Revenue beat(4)3.66%
Revenue beat(8)4
Avg Revenue beat(8)-1.54%
Revenue beat(12)5
Avg Revenue beat(12)-1.13%
Revenue beat(16)7
Avg Revenue beat(16)-0.89%
PT rev (1m)0%
PT rev (3m)-5.24%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-12.3%
EPS NY rev (1m)0%
EPS NY rev (3m)-6.09%
Revenue NQ rev (1m)-0.97%
Revenue NQ rev (3m)3.03%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.44%
Valuation
Industry RankSector Rank
PE 38.13
Fwd PE 24.97
P/S 1.96
P/FCF 23.63
P/OCF 14.95
P/B 2.01
P/tB N/A
EV/EBITDA 17.39
EPS(TTM)1.67
EY2.62%
EPS(NY)2.55
Fwd EY4.01%
FCF(TTM)2.69
FCFY4.23%
OCF(TTM)4.26
OCFY6.69%
SpS32.43
BVpS31.66
TBVpS-0.87
PEG (NY)0.81
PEG (5Y)5.99
Graham Number34.49
Profitability
Industry RankSector Rank
ROA 2.34%
ROE 3.84%
ROCE 4.3%
ROIC 3.29%
ROICexc 3.33%
ROICexgc 10.5%
OM 6.39%
PM (TTM) 3.75%
GM 32.45%
FCFM 8.31%
ROA(3y)4.66%
ROA(5y)5.25%
ROE(3y)7.28%
ROE(5y)9.09%
ROIC(3y)6%
ROIC(5y)6.74%
ROICexc(3y)6.37%
ROICexc(5y)6.98%
ROICexgc(3y)14.95%
ROICexgc(5y)15.39%
ROCE(3y)7.84%
ROCE(5y)8.8%
ROICexgc growth 3Y-9.42%
ROICexgc growth 5Y-3.25%
ROICexc growth 3Y-18.51%
ROICexc growth 5Y-11.8%
OM growth 3Y-2.14%
OM growth 5Y1.69%
PM growth 3Y-2.08%
PM growth 5Y2.27%
GM growth 3Y4.06%
GM growth 5Y5.54%
F-Score3
Asset Turnover0.62
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 4.45
Debt/EBITDA 2.7
Cap/Depr 65.9%
Cap/Sales 4.82%
Interest Coverage 250
Cash Conversion 95.79%
Profit Quality 221.43%
Current Ratio 2.43
Quick Ratio 2.06
Altman-Z 3.11
F-Score3
WACC9.72%
ROIC/WACC0.34
Cap/Depr(3y)85.02%
Cap/Depr(5y)89.69%
Cap/Sales(3y)4.65%
Cap/Sales(5y)4.54%
Profit Quality(3y)129.96%
Profit Quality(5y)134.79%
High Growth Momentum
Growth
EPS 1Y (TTM)-15.66%
EPS 3Y-2.79%
EPS 5Y6.36%
EPS Q2Q%25.71%
EPS Next Y47.1%
EPS Next 2Y31.71%
EPS Next 3Y16.78%
EPS Next 5Y19.42%
Revenue 1Y (TTM)11.81%
Revenue growth 3Y10.75%
Revenue growth 5Y9.97%
Sales Q2Q%21.3%
Revenue Next Year18.13%
Revenue Next 2Y12.77%
Revenue Next 3Y9.23%
Revenue Next 5Y9.3%
EBIT growth 1Y-18.82%
EBIT growth 3Y8.38%
EBIT growth 5Y11.83%
EBIT Next Year206.59%
EBIT Next 3Y48.86%
EBIT Next 5Y35.49%
FCF growth 1Y42.8%
FCF growth 3Y51.16%
FCF growth 5Y38.93%
OCF growth 1Y43.49%
OCF growth 3Y30.31%
OCF growth 5Y27.52%

TRANSCAT INC / TRNS FAQ

What is the fundamental rating for TRNS stock?

ChartMill assigns a fundamental rating of 5 / 10 to TRNS.


Can you provide the valuation status for TRANSCAT INC?

ChartMill assigns a valuation rating of 3 / 10 to TRANSCAT INC (TRNS). This can be considered as Overvalued.


What is the profitability of TRNS stock?

TRANSCAT INC (TRNS) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for TRNS stock?

The Price/Earnings (PE) ratio for TRANSCAT INC (TRNS) is 38.13 and the Price/Book (PB) ratio is 2.01.


What is the financial health of TRANSCAT INC (TRNS) stock?

The financial health rating of TRANSCAT INC (TRNS) is 6 / 10.